Literature DB >> 2186832

Long term propranolol treatment and changes in body weight after myocardial infarction.

S Rössner1, C L Taylor, R P Byington, C D Furberg.   

Abstract

OBJECTIVE: To determine the effect of long term propranolol treatment on body weight.
DESIGN: Retrospective analysis of data from a placebo controlled randomised double blind clinical trial (the beta blocker heart attack trial). PATIENTS: 3837 Men and women randomised 5-21 days after an acute myocardial infarction to treatment with placebo or propranolol for up to 40 months. Patients were followed up at annual visits. MAIN OUTCOME MEASURE: Changes in body weight.
RESULTS: At the first annual visit patients treated with propranolol had gained more weight than those given placebo (mean weight gain 2.3 kg v 1.2 kg respectively, mean difference 1.2 kg (95% confidence interval 0.9 to 1.5]. These group differences remained at the second and third annual visits. The difference in weight gain could not be explained by discrepancies in the use of diuretics or in physical activity and was similar in patients of both sexes and of all ages.
CONCLUSION: Long term beta blockade results in a sustained weight gain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2186832      PMCID: PMC1662668          DOI: 10.1136/bmj.300.6729.902

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  2 in total

1.  Unbalanced repeated-measures models with structured covariance matrices.

Authors:  R I Jennrich; M D Schluchter
Journal:  Biometrics       Date:  1986-12       Impact factor: 2.571

2.  Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.

Authors:  R P Byington
Journal:  Control Clin Trials       Date:  1984-12
  2 in total
  20 in total

Review 1.  Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.

Authors:  Valentina Medici; Stephen A McClave; Keith R Miller
Journal:  Curr Gastroenterol Rep       Date:  2016-01

2.  Changes in body composition in patients with left ventricular systolic dysfunction initiated on beta-blocker therapy.

Authors:  Lee Ingle; Alan S Rigby; Sean Carroll; Ron Butterly; Rod F King; Carlton B Cooke; John Gjf Cleland; Andrew L Clark
Journal:  Exp Clin Cardiol       Date:  2007

Review 3.  Antihypertensive drugs and glucose metabolism.

Authors:  Christos V Rizos; Moses S Elisaf
Journal:  World J Cardiol       Date:  2014-07-26

Review 4.  Effects of exercise training on abdominal obesity and related metabolic complications.

Authors:  B Buemann; A Tremblay
Journal:  Sports Med       Date:  1996-03       Impact factor: 11.136

Review 5.  Lipid effects of antihypertensive medications.

Authors:  Roderick Deano; Matthew Sorrentino
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

Review 6.  Mechanism of differential effects of antihypertensive agents on serum lipids.

Authors:  R D Brook
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

Review 7.  Bodyweight change as an adverse effect of drug treatment. Mechanisms and management.

Authors:  H Pijl; A E Meinders
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

8.  Beta-blockers may reduce intrusive thoughts in newly diagnosed cancer patients.

Authors:  Monica E Lindgren; Christopher P Fagundes; Catherine M Alfano; Stephen P Povoski; Doreen M Agnese; Mark W Arnold; William B Farrar; Lisa D Yee; William E Carson; Carl R Schmidt; Janice K Kiecolt-Glaser
Journal:  Psychooncology       Date:  2012-12-17       Impact factor: 3.894

Review 9.  Preventive treatment of migraine: effect on weight.

Authors:  William B Young
Journal:  Curr Pain Headache Rep       Date:  2008-06

Review 10.  Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockers.

Authors:  Prakash Deedwania
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-11-08       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.